This illustration, created at the CDC, reveals ultrastructural morphology exhibited by the 2019 novel coronavirus, Covid-19. Credit: CDC/ Alissa Eckert, Dan Higgins.

Visit our Covid-19 microsite for the latest coronavirus news, analysis and updates

Follow the latest updates of the outbreak on our timeline.

Go deeper with GlobalData

Premium Insights

The gold standard of business intelligence.

Find out more

Related Company Profiles

View all

Brii Biosciences has signed a memorandum of understanding with Columbia University to provide funding for research on solutions to treat, prevent and diagnose coronaviruses, including Covid-19.

The partners also plan to form a joint collaboration model that will allow the use of their respective research and development (R&D), expertise and other contributions to accelerate the research.

Columbia University Vagelos College of Physicians and Surgeons medicine professor David Ho said: “As an international university with a global network of research collaborators, clinicians and patient-care capabilities, Columbia feels a special obligation to focus on public health threats such as coronaviruses, and our research teams are working now to identify potential antiviral drugs and antibodies against Covid-19.

“Through this generous funding from Brii Bio, we look forward to building on our current research to create a truly holistic approach to diagnosis, treatment and prevention.”

How well do you really know your competitors?

Access the most comprehensive Company Profiles on the market, powered by GlobalData. Save hours of research. Gain competitive edge.

Company Profile – free sample

Thank you!

Your download email will arrive shortly

Not ready to buy yet? Download a free sample

We are confident about the unique quality of our Company Profiles. However, we want you to make the most beneficial decision for your business, so we offer a free sample that you can download by submitting the below form

By GlobalData
Visit our Privacy Policy for more information about our services, how we may use, process and share your personal data, including information of your rights in respect of your personal data and how you can unsubscribe from future marketing communications. Our services are intended for corporate subscribers and you warrant that the email address submitted is your corporate email address.

Brii Biosciences will provide the funding as an unrestricted grant to enable a framework for strategic alliances in areas of complementary expertise and resources.

Brii Biosciences CEO Zhi Hong added: “As a company dedicated to improving public health in China and globally, we know that threats such as coronaviruses can be met only if governments, academic institutions and private entities such as Brii Bio work together.

“Our support for Columbia offers meaningful assistance in dealing with the current public health crisis, and we are excited to be exploring a new collaboration model for addressing future public health challenges.”